Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Vertex Pharmaceuticals claims novel protein kinase inhibitors

March 24, 2009

Nereus Pharmaceuticals has begun a phase II trial of NPI-2358 in NSCLC

March 24, 2009

Poniard to focus resources on oncology drug picoplatin

March 23, 2009

Enzon initiates treatment of patients with survivin antagonist EZN-3042 under IND

March 23, 2009

Bristol-Myers Squibb withdraws marketing authorization application for Ixempra

March 23, 2009

SciClone completes patient enrollment in phase II trial of pancreatic cancer drug RP-101

March 23, 2009

Alchemia and SDP enter drug discovery agreement for anticancer drugs targeting SK1

March 23, 2009

Glivec recommended for use in Europe in postsurgery gastrointestinal tumors

March 23, 2009

Biokine initiates Israeli phase I/IIa clinical study of BKT-140 for myeloma

March 20, 2009

OSI submits sNDA for Tarceva as first-line maintenance therapy in NSCLC

March 20, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...